Loading clinical trials...
Loading clinical trials...
This trial is designed to determine whether modifying the dose of isoniazid for individuals according to their n-acetyltransferase 2 (NAT2) genotype could increase the probability of achieving equival...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Stanford University
Collaborators
NCT05285202 · Tuberculosis, Pulmonary, Mycobacterium Tuberculosis Infection
NCT05069688 · Pediatric HIV Infection, Tuberculosis Infection
NCT05342064 · Tuberculosis, HIV Coinfection, and more
NCT06221488 · Tuberculosis, Tuberculosis Infection
NCT06033807 · Tuberculosis, Latent Tuberculosis Infection
Federal University of Mato Grosso do Sul
Campo Grande, Mato Grosso do Sul
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions